SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,628.37 |
| Enterprise Value ($M) | 3,578.02 |
| Book Value ($M) | 911.45 |
| Book Value / Share | 8.18 |
| Price / Book | 3.98 |
| NCAV ($M) | 910.21 |
| NCAV / Share | 8.17 |
| Price / NCAV | 3.99 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.11 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 36.47 |
| Current Ratio | 36.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 936.65 |
| Assets | 937.89 |
| Liabilities | 26.44 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Viking Global Investors Lp | 0.60 | -85.97 | |
| 13G/A | Vanguard Group Inc | 9.17 | 0.00 | |
| 13G/A | State Street Corp | 4.20 | -18.61 | |
| 13G/A | BlackRock, Inc. | 4.90 | -28.16 | |
| 13G/A | Fmr Llc | 15.00 | 37.37 | |
| 13G/A | Millennium Management Llc | 0.40 | -91.64 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 948,004 | 3,956,048 | 23.96 | |
| 693,167 | 4,733,388 | 14.64 | |
| 417,135 | 3,635,968 | 11.47 | |
| 960,612 | 7,374,564 | 13.03 | |
| 586,536 | 2,991,176 | 19.61 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VERU – Veru Inc. | VINC – Vincerx Pharma, Inc. |
| VIRX – Viracta Therapeutics, Inc. | VRPX – Virpax Pharmaceuticals, Inc. |
| VSTM – Verastem, Inc. |
Financial data and stock pages provided by
Fintel.io